| Issue Type | XXXX |
|---|---|
| Country | Brazil |
| Industry | XXXX |
| Region | XXXX |
| Maturity Date | 2031-03-18 |
| Par Value | 1000 |
| Callable | XXXX |
| Next Call Date | XXXX |
| Call Type | XXXX |
| Call Price (%) | XXXX |
| Series | XXXX |
| Class | XXXX |
| Maturity Structure | XXXX |
| Amount Outstanding (mil) |
| Coupon | 10.23 |
|---|---|
| Coupon Type | XXXX |
| Coupon Frequency | XXXX |
| First Coupon Date | XXXX |
| Last Coupon Date | XXXX |
| Sinking Fund | XXXX |
|---|---|
| Security | XXXX |
| Subordination | XXXX |
| Debt Type | XXXX |
| Issue Date | XXXX |
|---|---|
| Dated Date | XXXX |
| Issue Size (mil) | |
| Min. Piece | XXXX |
| Min. Increment | XXXX |
This Eurofarma Laboratorios SA corporate debenture has a X.X % floating rate rate coupon paid on a XXXX basis. It was issued on MAR 12, 2000 with an issue size of XXX million BRL and matures on DEC 9, 2000 with a last coupon date of FEB 28, 2020. |
Eurofarma Laboratorios SA, founded in 1972 and headquartered in São Paulo, Brazil, is a prominent pharmaceutical company dedicated to developing, manufacturing, and marketing innovative medications aimed at enhancing health and well-being. The company offers a diverse range of products, including branded and generic pharmaceuticals, over-the-counter medications, and biological therapies.